Aardvark Therapeutics Faces Shareholder Lawsuit Over ARD-101 Safety Claims#Levi_&_Korsinsky#Aardvark_Therapeutics#NASDAQ_AARD
Aardvark Therapeutics Faces Shareholder Lawsuit Over ARD-101 Safety Claims
Aardvark Therapeutics, Inc. is facing a securities class action lawsuit regarding safety claims of ARD-101. Investors urged to respond by October 13, 2026.
third-news.com
September 30, 2026 at 5:05 PM
Aardvark Therapeutics Faces Shareholder Lawsuit Over ARD-101 Safety Claims#Levi_&_Korsinsky#Aardvark_Therapeutics#NASDAQ_AARD
Moore Law PLLC Investigates Claims Against Aardvark Therapeutics, Inc. Following Stock Price Plummet#United_States#New_York#Moore_Law_PLLC#Aardvark_Therapeutics#NASDAQ_AARD
Moore Law PLLC Investigates Claims Against Aardvark Therapeutics, Inc. Following Stock Price Plummet
Moore Law PLLC is currently probing Aardvark Therapeutics, Inc. for potentially misleading information regarding their drug safety, following a sharp stock price decline.
third-news.com
September 10, 2026 at 8:06 PM
Moore Law PLLC Investigates Claims Against Aardvark Therapeutics, Inc. Following Stock Price Plummet#United_States#New_York#Moore_Law_PLLC#Aardvark_Therapeutics#NASDAQ_AARD
Important Litigation Notice for Aardvark Therapeutics Investors: Act Before Deadline#United_States#San_Diego#Aardvark_Therap#Shareholders_F#NASDAQ_AARD
Important Litigation Notice for Aardvark Therapeutics Investors: Act Before Deadline
Investors who lost $100,000 or more in Aardvark Therapeutics, Inc. have a deadline approaching on October 31, 2026. Contact Shareholders Foundation for details.
third-news.com
August 20, 2026 at 6:46 PM
Important Litigation Notice for Aardvark Therapeutics Investors: Act Before Deadline#United_States#San_Diego#Aardvark_Therap#Shareholders_F#NASDAQ_AARD